{
  "generated": "2025-11-05T06:50:55.241896+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/resveratrol-meta-glu17/metabolic/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "META-GLU17_01",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "insulin_sensitivity",
      "population": "Adults with insulin sensitivity concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/resveratrol-meta-glu17-01",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-01",
      "citation": "META-GLU17_01 (2015); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with insulin sensitivity concerns; Outcome: insulin_sensitivity; DOI: 10.1234/resveratrol-meta-glu17-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "META-GLU17_02",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "insulin_sensitivity",
      "population": "Adults with insulin sensitivity concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/resveratrol-meta-glu17-02",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-02",
      "citation": "META-GLU17_02 (2016); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with insulin sensitivity concerns; Outcome: insulin_sensitivity; DOI: 10.1234/resveratrol-meta-glu17-02; Adverse Events: None reported."
    },
    {
      "study_id": "META-GLU17_03",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "metabolic_journal",
      "outcome": "insulin_sensitivity",
      "population": "Adults with insulin sensitivity concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/resveratrol-meta-glu17-03",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-03",
      "citation": "META-GLU17_03 (2017); Journal: metabolic_journal; Design: randomized controlled trial; Population: Adults with insulin sensitivity concerns; Outcome: insulin_sensitivity; DOI: 10.1234/resveratrol-meta-glu17-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/resveratrol-meta-glu17-01",
      "study_ids": [
        "META-GLU17_01"
      ],
      "primary_study_id": "META-GLU17_01",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/resveratrol-meta-glu17-02",
      "study_ids": [
        "META-GLU17_02"
      ],
      "primary_study_id": "META-GLU17_02",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/resveratrol-meta-glu17-03",
      "study_ids": [
        "META-GLU17_03"
      ],
      "primary_study_id": "META-GLU17_03",
      "url": "https://doi.org/10.1234/resveratrol-meta-glu17-03"
    }
  ],
  "manifest_hash": "sha256:6c8f2cec9af3b7f9fa8ec97a53327e43150c391de35b8dcd10e784dda26b25be"
}
